Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Titan Biotech's share price for the quarter that ended in Dec. 2023 was ₹409.6. Titan Biotech's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 8 Mil. Therefore, Titan Biotech's market cap for the quarter that ended in Dec. 2023 was ₹3,385 Mil.
Titan Biotech's quarterly market cap
increased
from Jun. 2023 (₹2,184 Mil) to Sep. 2023 (₹2,904 Mil) and
increased
from Sep. 2023 (₹2,904 Mil) to Dec. 2023 (₹3,385 Mil).
Titan Biotech's annual market cap
increased
from Mar. 2021 (₹1,533 Mil) to Mar. 2022 (₹2,166 Mil) but then
declined
from Mar. 2022 (₹2,166 Mil) to Mar. 2023 (₹1,627 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Titan Biotech's Enterprise Value for Today is ₹4,077 Mil.
Titan Biotech Market Cap Historical Data
The historical data trend for Titan Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Titan Biotech's Market Cap
For the Biotechnology subindustry, Titan Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Titan Biotech's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Titan Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Titan Biotech's Market Cap falls into.
Titan Biotech Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Titan Biotech's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Titan Biotech (BOM:524717) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Titan Biotech Market Cap Related Terms
Thank you for viewing the detailed overview of Titan Biotech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The Company's business activity falls within a single primary business segment which is business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:524717 has been successfully added to your 